Delivery Order SPE2DB22D3011-SPE2DB23FP8AL
- Not listed
- This federal contract award is a delivery order (SPE2DB22FV8E8) valued at $1,710.64, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the VARIVAX vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves...
- This federal contract award is for the delivery of VARIVAX vaccine with diluents, valued at $79,995.50, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA), a combat support agency of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $1,895.48 and a completion date of February 15, 2023. It is a firm fixed-price delivery order contract, without any set-aside designation,...
- This federal contract award is for the delivery of VARIVAX vaccine with diluents to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., under a Firm Fixed Price delivery order. The award has a ceiling value of $91,878.60 and an ultimate completion date of November 5, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This federal contract award, valued at $4,705.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of VARIVAX vaccine with diluents, a critical pharmaceutical product used for infectious disease prevention. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VARIVAX vaccines with diluents. The contract has a ceiling value of $2,848.11 and a completion date of February 22, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which serves as the parent company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of VARIVAX vaccine with diluents, with a ceiling value of $4,779.85. The award has an ultimate completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently...
- This federal contract award, with an ID of SPE2DB22D1200|SPE2DB25FN0EB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VARIVAX vaccine with diluents, with a total ceiling value of $6,192.66 and a period of performance ending on February 24, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,559.70 firm fixed-price delivery order is for the supply of VARIVAX vaccine with diluents, with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This...
- This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of VARIVAX vaccine with diluents, with a ceiling value of $2,867.91 and an ultimate completion date of June 11, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 31, 2025....
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FP8ALDelivery Order
This federal contract award, with the ID SPE2DB22D3011|SPE2DB23FP8AL, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of VARIVAX vaccine with diluents, with a ceiling value of $79,995.50 and an ultimate completion date of December 19, 2022. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is for full and open competition, with no set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $80.0k | 11/28/22 |